Literature DB >> 24959500

Behaviour of disc oedema during and after amiodarone optic neuropathy: case report.

Med Alejandro Martínez-LóPez-Portillo1, Bertha O Martínez-Gamero2, Jibran Mohamed-Noriega3, Med Humberto Cavazos-Adame4, Med Jesús Mohamed-Hamsho5.   

Abstract

A 73-year-old woman with atrial fibrillation treated with Amiodarone presented with Optic Disc oedema in right eye (OD). Using Optical Coherence Tomography (OCT) we describe the impact of this neuropathy on Retinal Nerve Fibre Layer (RNFL). At diagnosis RNFL average was of 188 μm OD and 77 μm in the left eye (OS), six months after discontinuation of the drug decreased to 40 μm in OD and 76 μm in OS. The RNFL average of OD presented a transient increase during the acute oedema that returned to normal levels during the first month after discontinuation of the drug and fell dramatically to 44 μm at the second month and 40 μm at the sixth month. We show there is axonal loss after amiodarone-associated optic neuropathy measured with OCT. The OCT may be used in these patients to document changes in RNFL in the follow-up.

Entities:  

Keywords:  Optic atrophy; Optic coherence tomography; Toxic neuropathy

Year:  2014        PMID: 24959500      PMCID: PMC4064863          DOI: 10.7860/JCDR/2014/8254.4262

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Amiodarone and optic neuropathy.

Authors:  Joel S Mindel
Journal:  Am Heart J       Date:  2008-07-07       Impact factor: 4.749

2.  Optic neuropathy in patients using amiodarone.

Authors:  Valerie Purvin; Aki Kawasaki; Francois-Xavier Borruat
Journal:  Arch Ophthalmol       Date:  2006-05

Review 3.  Amiodarone-associated optic neuropathy: a critical review.

Authors:  Rod S Passman; Charles L Bennett; Joseph M Purpura; Rashmi Kapur; Lenworth N Johnson; Dennis W Raisch; Dennis P West; Beatrice J Edwards; Steven M Belknap; Dustin B Liebling; Mathew J Fisher; Athena T Samaras; Lisa-Gaye A Jones; Katrina-Marie E Tulas; June M McKoy
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

4.  Features of amiodarone-induced optic neuropathy.

Authors:  D C Macaluso; W T Shults; F T Fraunfelder
Journal:  Am J Ophthalmol       Date:  1999-05       Impact factor: 5.258

Review 5.  Ocular side effects of amiodarone.

Authors:  M Mäntyjärvi; K Tuppurainen; K Ikäheimo
Journal:  Surv Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 6.048

Review 6.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

7.  Amiodarone induced optic neuropathy.

Authors:  P K Nagra; R Foroozan; P J Savino; I Castillo; R C Sergott
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

8.  Bilateral optic neuropathy and permanent loss of vision after treatment with amiodarone.

Authors:  Marko Kervinen; Aura Falck; Merja Hurskainen; Nina Hautala
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

9.  Optic nerve ultrastructure following amiodarone therapy.

Authors:  A M Mansour; J E Puklin; R O'Grady
Journal:  J Clin Neuroophthalmol       Date:  1988-12

10.  Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta.

Authors:  Kurt-Wolfram Sühs; Katharina Hein; Jens R Pehlke; Barbara Käsmann-Kellner; Ricarda Diem
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

  10 in total
  1 in total

Review 1.  The role of Optical Coherence Tomography in optic neuropathies.

Authors:  Raluca Eugenia Iorga; Andreea Moraru; Manuela Ramona Ozturk; Dănuţ Costin
Journal:  Rom J Ophthalmol       Date:  2018 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.